MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer.
Luo Y, Ma S, Sun Y, Peng S, Zeng Z, Han L, Li S, Sun W, Xu J, Tian X, Wang F, Wu Q, Xiao Y, Zhang J, Gong Y, Xie C.
Luo Y, et al. Among authors: zeng z.
Int J Biol Sci. 2021 Apr 12;17(7):1671-1681. doi: 10.7150/ijbs.57964. eCollection 2021.
Int J Biol Sci. 2021.
PMID: 33994852
Free PMC article.